Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

Ventilatory Settings and Monitoring Variables Associated With Weaning Failure in Critically Ill Patients: A Retrospective Study

OBSERVATIONALInicio: 1 de dic de 2024ID: NCT06683781

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo As Maintenance Therapy After First Line Induction Therapy in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

INTERVENTIONALInicio: 8 de sept de 2023ID: NCT05894239

ReclutandoFase 2ClinicalTrials.gov

A Randomized, Participant- and Investigator-blinded, Controlled, Parallel Group Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LXE408 in Participants With Chronic Chagas Disease Without Severe Organ Dysfunction.

INTERVENTIONALInicio: 28 de abr de 2025ID: NCT06632600

ReclutandoFase 2ClinicalTrials.gov

A Phase I/II Randomized Multi-Cohort Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors

INTERVENTIONALInicio: 4 de mar de 2025ID: NCT06796907

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Moderate to Severe Active Systemic Lupus Erythematosus While on Background Standard of Care Therapy

INTERVENTIONALInicio: 14 de mar de 2024ID: NCT05835310

ReclutandoFase 1ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Systemic Sclerosis

INTERVENTIONALInicio: 4 de jul de 2022ID: NCT05016804

ReclutandoFase 3ClinicalTrials.gov

An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer

INTERVENTIONALInicio: 14 de abr de 2024ID: NCT06312176

ReclutandoFase 2ClinicalTrials.gov

An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis

INTERVENTIONALInicio: 23 de may de 2023ID: NCT05848258

ReclutandoFase 2ClinicalTrials.gov

A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

INTERVENTIONALInicio: 9 de oct de 2024ID: NCT06470048

ReclutandoClinicalTrials.gov

Atrial Electromechanical Alteration as a Predictor of Arrhythmias in the Postoperative Period After Cardiovascular Surgery

OBSERVATIONALInicio: 6 de feb de 2026ID: NCT07388108

ReclutandoFase 3ClinicalTrials.gov

Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

INTERVENTIONALInicio: 10 de oct de 2022ID: NCT05508789

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma

INTERVENTIONALInicio: 12 de mar de 2025ID: NCT06615479

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis

INTERVENTIONALInicio: 3 de dic de 2025ID: NCT06979453

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, Without Type 2 Diabetes

INTERVENTIONALInicio: 6 de feb de 2026ID: NCT07321886

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Open-Label, Extension Clinical Trial to Evaluate Safety and Efficacy of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis (PBC)

INTERVENTIONALInicio: 16 de jul de 2024ID: NCT06427395

ReclutandoFase 2ClinicalTrials.gov

An Open-Label Multinational, Multicenter Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

INTERVENTIONALInicio: 3 de abr de 2023ID: NCT05769777

ReclutandoFase 2ClinicalTrials.gov

An Open-label, Long-term Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

INTERVENTIONALInicio: 25 de feb de 2025ID: NCT06712823

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-experienced Participants With Active Psoriatic Arthritis

INTERVENTIONALInicio: 9 de ene de 2025ID: NCT06807424

ReclutandoClinicalTrials.gov

Epidemiological and Molecular Colorectal Cancer Registry

OBSERVATIONALInicio: 1 de may de 2012ID: NCT02781337

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults With Type I, III, or IV Osteogenesis Imperfecta (OI)

INTERVENTIONALInicio: 12 de dic de 2025ID: NCT07062588